tiprankstipranks
Trending News
More News >
Taiko Pharmaceutical Co., Ltd. (JP:4574)
:4574
Japanese Market

Taiko Pharmaceutical Co., Ltd. (4574) Income Statement

Compare
0 Followers

Taiko Pharmaceutical Co., Ltd. Income Statement

Last quarter (Q2 2025), Taiko Pharmaceutical Co., Ltd.'s total revenue was ¥1.26B, a decrease of -14.90% from the same quarter last year. In Q2, Taiko Pharmaceutical Co., Ltd.'s net income was ¥-13.00M. See Taiko Pharmaceutical Co., Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
¥ 6.40B¥ 6.29B¥ 6.12B¥ 5.04B¥ 10.72B
Gross Profit
¥ 3.48B¥ 3.67B¥ 2.58B¥ 1.08B¥ 2.75B
Operating Expenses
¥ 3.02B¥ 3.04B¥ 3.58B¥ 4.16B¥ 7.69B
Depreciation and Amortization
¥ 265.00M¥ 256.00M¥ 704.00M¥ -671.00M¥ -620.00M
EBITDA
¥ 724.00M¥ 882.00M¥ -2.85B¥ -3.75B¥ -5.57B
Operating Income
¥ 459.00M¥ 629.00M¥ -1.00B¥ -3.08B¥ -4.95B
Other Income/Expenses
¥ 499.00M¥ -64.00M¥ -2.56B¥ -1.79B¥ -3.94B
Pretax Income
¥ 958.00M¥ 565.00M¥ -3.56B¥ -4.87B¥ -8.89B
Net Income
¥ 923.00M¥ 898.00M¥ -3.61B¥ -4.89B¥ -9.59B
Per Share Metrics
Basic EPS
¥ 18.37¥ 17.89¥ -76.25¥ -112.24¥ -220.48
Diluted EPS
¥ 18.37¥ 17.89¥ -76.25¥ -112.24¥ -220.48
Weighted Average Shares Outstanding
50.24M 50.18M 47.36M 43.60M 43.51M
Weighted Average Shares Outstanding (Diluted)
50.24M 50.18M 47.36M 43.60M 43.51M
Currency in JPY

Taiko Pharmaceutical Co., Ltd. Earnings and Revenue History